comparemela.com

Latest Breaking News On - Pseudomonas aeruginosa - Page 4 : comparemela.com

Deadly 'Superbug' Bacteria Detected In Soda Fountains

A recent study found that a shocking 41% of fast-food restaurant soda fountains were contaminated with some of the deadliest “superbug” germs known to science, including antibiotic-resistant Pseudomonas aeruginosa and Campylobacter jejuni. What do you think?

Cathy-larson
Oscar-thakuria
Creed-peterson
Disaster
Accident
Antimicrobial-resistance
Gram-negative-bacteria
Creed-peterson
Antibiotic-resistant-bacteria
Campylobacterota
Seudomonadales

'Overlooked' problem of bacteria in fast-food soda fountains. How risky is that drink?

The findings resulted somewhat coincidentally as researchers studied water sources in a California community known to have toxic drinking water.

Riverside-county
California
United-states
Hollins-university
Virginia
Loma-linda
Coachella-valley
Oasis-mobile-home-park
Joan-rose
Kristin-lorge
Bryan-sinclair
Water-research-at-michigan-state-university

Antimicrobial Resistance Market to Reach $9.5 Billion, Globally, by 2032 at 7.6% CAGR: Allied Market Research

/PRNewswire/ Allied Market Research published a report, titled, "Antimicrobial Resistance Market By Drug Class (Combination Therapies, Tetracyclines,.

Hong-kong
China
Portland
Oregon
United-states
India
Pune
Maharashtra
United-kingdom
America
David-correa
Pawan-kumar

IDWeek 2023: Shionogi and Qpex Biopharma, Inc. Continue Longstanding Commitment to Addressing Unmet Needs in Infectious Disease

FLORHAM PARK, N.J., September 07, 2023 Shionogi Inc., the United States subsidiary of Shionogi & Co., Ltd., (Head Office: Osaka, Japan; Chief Executive Officer: Isao Teshirogi, Ph.D.), announced the upcoming presentation of new data at IDWeek 2023 (October 11-15, 2023) on its investigational oral antiviral for COVID-19, ensitrelvir (Generic name: ensitrelvir fumaric acid, Code No.: S-217622, hereafter "ensitrelvir"), and Fetroja® (cefiderocol), an antibiotic marketed under the brand name Fetcro

Japan
Osaka
United-states
Japanese
David-nicolau
Isao-teshirogi
Olga-lomovskaya
Shionogi-co-ltd
Head-office
Antimicrobial-surveillance-program
Qpex-biopharma-inc
Global-antibiotic-research

This virus could be a treatment for antibiotic-resistant bacteria infections

Researchers successfully used a virus to treat patients with an antibiotic-resistant bacterial infection, achieving good clinical outcomes in 86.6% of cases.

Antibiotic-resistant
Acterial-infection
Pseudomonas-aeruginosa
Asa16
Clinical-outcomes
Virus-treatment
Ntibiotic-resistance-infection
Infection
Infection-control
Virus

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.